Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Likewise, previous reported clinical predictors of osteogenic and adipogenic differentiation, such as sex, osteoporosis, vitamin D supplementation, or alcohol consumption, were not associated with cell abundance for any of the clusters.

Source: Donor specific subpopulation abundance aligns with differentiation properties. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Laboratory / cell research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

To explore a common molecular signature predictive for osteogenic potential of primary human cells, we combined molecular profiling by single-cell RNA-seq with in vitro differentiation assays from primary cultures derived from women and men, with and without osteoporosis, that were established from bone biopsies removed during orthopedical surgery or from marrow aspirates of the iliac crest (Fig.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

An ITGA11 expressing subpopulation as predictor for the donor-specific osteogenic capacity of stromal cells

Study design awaiting verification · Bone Research · 2026

Original publication title

An ITGA11 expressing subpopulation as predictor for the donor-specific osteogenic capacity of stromal cells

Ali Jasim Mohammad Jamil; Kaja Madsen; Souad Daamouch; Birgitte Villadsen; Chao Ma; Shakespeare Jeromdesella; Mikkel Ørnfeldt Nørgård; Emilie Grupe; Maria Bruun Jakobsson; Yuting Wang; Eri Takematsu; Liming Zhao; Stuart Barry Goodman; Lawrence Henry Goodnough; Charles Kwok Fai Chan; Thomas Levin Andersen; Moustapha Kassem; Alexander Rauch

© The Author(s) 2026

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Stromal progenitor cells of bone marrow origin are non-hematopoietic cells that give rise to osteoblasts and adipocytes in the postnatal organism. Marrow stromal cells (also known as mesenchymal stem cells: MSCs) are currently being employed in a large number of clinical trials for regenerative purposes post in vitro expansion. However, the clinical outcome has been variable, which might in part be due to the heterogeneity of the cells and the lack of a defined cell product with a molecular signature that favors tissue regeneration.

In this study, we determined the cellular heterogeneity of primary stromal cultures and examined how inter-donor variation in subpopulation composition contributes to the differentiation potential of primary cultures. We profiled 136 014 stromal progenitors from 26 donors and identified 5 subpopulations that were linked to distinct bone-related pathways and genetic traits of bone mineral density and morphology. Abundance of one cluster characterized by high expression of ITGA11 (integrin alpha-11) and genes related to matrix function, collagen organization, and elevated expression upon lineage commitment was positively correlated with osteoblastic differentiation capacity in vitro.

In addition, ITGA11 protein expression in progenitor cells was a predictive marker for matrix mineralization in vitro and ectopic bone formation in vivo. Sorting stromal progenitors into ITGA11high and ITGA11low cells established cultures with high and low osteoblastic differentiation potential and revealed transcriptional differences reflective of the subpopulation-specific signature, which was not affected by siRNA-mediated knockdown of ITGA11 expression. Our findings corroborate the presence of an extensive donor-dependent cellular heterogeneity that persists in cultured stromal cells, and that ITGA11 can be employed as a marker for isolating cells with high bone-forming potential, a feature likely to benefit clinical trials of bone regeneration.

Authors’ abstract

Stromal progenitor cells of bone marrow origin are non-hematopoietic cells that give rise to osteoblasts and adipocytes in the postnatal organism. Marrow stromal cells (also known as mesenchymal stem cells: MSCs) are currently being employed in a large number of clinical trials for regenerative purposes post in vitro expansion. However, the clinical outcome has been variable, which might in part be due to the heterogeneity of the cells and the lack of a defined cell product with a molecular signature that favors tissue regeneration.

In this study, we determined the cellular heterogeneity of primary stromal cultures and examined how inter-donor variation in subpopulation composition contributes to the differentiation potential of primary cultures. We profiled 136 014 stromal progenitors from 26 donors and identified 5 subpopulations that were linked to distinct bone-related pathways and genetic traits of bone mineral density and morphology. Abundance of one cluster characterized by high expression of ITGA11 (integrin alpha-11) and genes related to matrix function, collagen organization, and elevated expression upon lineage commitment was positively correlated with osteoblastic differentiation capacity in vitro.

In addition, ITGA11 protein expression in progenitor cells was a predictive marker for matrix mineralization in vitro and ectopic bone formation in vivo. Sorting stromal progenitors into ITGA11high and ITGA11low cells established cultures with high and low osteoblastic differentiation potential and revealed transcriptional differences reflective of the subpopulation-specific signature, which was not affected by siRNA-mediated knockdown of ITGA11 expression. Our findings corroborate the presence of an extensive donor-dependent cellular heterogeneity that persists in cultured stromal cells, and that ITGA11 can be employed as a marker for isolating cells with high bone-forming potential, a feature likely to benefit clinical trials of bone regeneration.

Publication and source details

Original title: An ITGA11 expressing subpopulation as predictor for the donor-specific osteogenic capacity of stromal cells

Ali Jasim Mohammad Jamil; Kaja Madsen; Souad Daamouch; Birgitte Villadsen; Chao Ma; Shakespeare Jeromdesella; Mikkel Ørnfeldt Nørgård; Emilie Grupe; Maria Bruun Jakobsson; Yuting Wang; Eri Takematsu; Liming Zhao; Stuart Barry Goodman; Lawrence Henry Goodnough; Charles Kwok Fai Chan; Thomas Levin Andersen; Moustapha Kassem; Alexander Rauch

Bone Research · 2026

© The Author(s) 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.https://doi.org/10.13039/501100003554Lundbeckfonden (Lundbeck Foundation)R335-2019-2195Rauch Alexander https://doi.org/10.13039/501100009708Novo Nordisk Fonden (Novo Nordisk Foundation)NNF22OC0078257NNF19OC0057449NNF22OC0075296Andersen Thomas Levin Kassem Moustapha Rauch Alexander https://doi.org/10.13039/501100004836Det Frie Forskningsråd (Danish Council for Independent Research)0134-00292BRauch Alexander https://doi.org/10.13039/501100004196Odense Universitetshospital (Odense University Hospital)98-A4534Rauch Alexander Danish 3R-center: https://en.3rcenter.dk/

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T22:19:31.445040+00:00

DOI: 10.1038/s41413-026-00536-2 · PMC13265797